PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1664252
PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1664252
Proteomics Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F
Global proteomics market is projected to witness a CAGR of 12.50% during the forecast period 2025-2032, growing from USD 29.70 billion in 2024 to USD 76.21 billion in 2032. The market's growth is supported by the rising requirement for personalized medicines, increasing demand for advanced and rapid diagnostic solutions, and growing emphasis on research and development activities. Continuous improvements in protein analysis technologies, such as mass spectrometry and bioinformatics, are enhancing the capabilities of proteomics, increasing its application across various fields such as clinical diagnostics and drug discovery.
Growing efforts of various companies to improve proteomics platforms are also supporting the market's expansion. In November 2024, Quantum-Si Incorporated, specializing in protein sequencing technology, and NVIDIA Corporation announced a partnership to develop the former's proteomics platform, Proteus, and improve their core technologies with the help of the latter's accelerated computing capabilities and artificial intelligence. The collaboration also aims to address the rising demand for Quantum-Si's protein sequencing and detection technology and bolster data processing speed. Rising investments and funding are allowing the development of proteomics technologies that ensure early disease detection. In February 2024, Alamar Biosciences, Inc., one of the leading precision proteomics companies, announced the first closing of USD 100 million in Series C financing. Such fundings are expected to accelerate the development of non-invasive tests for diseases with significant unmet requirements and bolster the discovery of biomarkers.
Furthermore, government initiatives are also playing a crucial role in the development of innovative strategies that play a crucial role in maintaining human health. In September 2023, the National Institutes of Health (NIH) awarded USD 50.3 million for multi-omics research on human diseases and health. Such fundings aim to advance multi-omics research, which integrates various biological data types, including proteomics, to improve the understanding of diseases and support the development of scalable research strategies.
Rising Prevalence of Infectious and Chronic Diseases Boosts Market Demand
The growing threat of various infectious and chronic diseases is boosting the global proteomics market size. As per the estimates of the National Cancer Institute (NCI), approximately 2 million cases of cancer are expected to be diagnosed in the United States in 2024. This increase is augmenting the requirement for proteomics as the field has emerged as a crucial tool for exploring the different biological changes observed in cancer. Cancer is characterized by abnormal growth of the cells, where the normal cell cycle is disrupted because of genetic factors. With the help of proteomics technology, researchers have identified important information, including signaling pathways and protein targets linked with cancer cell growth.
The rising burden of infectious diseases is also bolstering the market's demand as, over the past few years, proteomics and mass spectrometry-based technologies have been increasingly deployed for providing insights into the biological factors behind infectious diseases and characterizing the molecular details of pathogen-host relationships.
Increasing Investments Towards Proteomics Technologies Support Market Expansion
The rising investments towards advancing and accelerating the development of novel technologies in spatial proteomics and protein purification are positively influencing the expansion of the global proteomics market. In December 2024, SYNCELL, Inc., one of the leading companies in spatial proteomics analysis and next-generation subcellular protein purification, announced the closing of a USD 15 million Series A funding round to accelerate and expand the commercialization of their Microscoop platform. The pioneering platform has the ability to discover novel protein components accurately and allows unbiased, high-precision, and spatial proteomic discovery in cells and subcellular tissues.
Other factors propelling the investments in the proteomics industry include increasing emphasis on therapeutic proteins and monoclonal antibodies and rising applications of proteomics in translational research and clinical trials to accelerate the development of novel therapeutic solutions. Additionally, the growing focus of research and academic institutions in the healthcare sector to enhance patient outcomes and ensure the development of novel treatment and diagnostic options is further driving innovations in the proteomics sector.
Drug Discovery Segment Accounts for Significant Share of the Market
The rising investments in drug discovery can be attributed to the growing burden of chronic diseases and increasing investments by the pharmaceutical sector in research and development activities to address the unmet medical requirements of the patient population. Rapid innovations in various sectors, including artificial intelligence, genomics, and proteomics, are revolutionizing drug discovery, enabling precise targeting of disease mechanisms and resulting in the development of more effective and personalized therapies. Increasing collaborations between pharmaceutical and biotech companies and academic institutions foster innovation, further accelerating the drug discovery processes and bolstering the global proteomics market demand.
Additionally, various leading players in proteomics solutions are significantly investing in expanding their facilities to support the rising requirements for proteomics in the drug discovery and development sectors. In October 2024, Evosep Biosystems announced the relocation of its headquarters in Odense, Denmark. The new facility will reinforce the company's commitment to improving diagnostic and drug discovery and development processes by serving as a hub for continued innovation. The relocation is also expected to help Evosep to expand its reach in the pharmaceutical industry and align its efforts for delivering end-to-end solutions that address the evolving requirements of the biotech and pharmaceutical companies.
North America Holds Major Market Share
The rapid growth of the North American proteomics market can be attributed to the rapid expansion of the biotechnology and healthcare industries in the region, the strong presence of leading market players, increasing investments towards the development of precision medicine, and the easy availability of novel therapeutic solutions. The demand for the next generation of medicines is driven by the rising cases of age-related disorders, neurological issues, immunological diseases, infections, and cancer, among others. Furthermore, the rising cases of hereditary disorders in countries such as Canada and the United States are also bolstering the region's proteomics requirement.
Additionally, the presence of leading research institutions and their rising efforts to support advancements in proteomics research also provide lucrative growth opportunities for the market. In October 2024, the University of Arkansas for Medical Sciences (UAMS) and Thermo Fisher Scientific Inc. announced the Thermo Fisher Scientific Center of Excellence for Proteomics launch at UAMS. The first industry-academic partnership of its kind in the United States, the development of the center is expected to allow clinicians and researchers to identify unique mechanisms that are responsible for driving various human diseases, novel drug targets, and new disease biomarkers.
Future Market Scenario (2025-2032F)
As per the global proteomics market analysis, the market is expected to observe significant growth in the coming years owing to the rapid expansion of the healthcare sector and the rising requirement for novel drug launches due to the exponential growth of the population and the rising threat of various chronic diseases. According to estimates from the United Nations, the global population is expected to reach 9.7 billion by 2050.
Medical research is expected to significantly benefit from the rising utilization of proteomics, allowing the identification of new therapeutic agents and targets and supporting the development of advanced prognostic and diagnostic tests. Additionally, the emerging technologies of protein arrays and chips are expected to enhance the throughput of analytical tests in the coming years.
The convergence of advanced technologies and rising proteomics applications in biotechnology, healthcare, and pharmaceutical industries are also expected to provide lucrative growth opportunities to the market in the coming years. Moreover, strategic collaborations between pharmaceutical companies, academic institutions, and proteomic service providers will play a crucial role in addressing the unmet requirements of the clinical sector.
Key Players Landscape and Outlook
The key players in the market are actively engaging in mergers, acquisitions, and collaborations to expand their product portfolio and their presence in the proteomics market. In July 2024, Thermo Fisher Scientific Inc. announced the completion of the acquisition of Olink Holding AB, one of the leading providers of next-generation proteomics solutions. The USD 3.1 billion deal is anticipated to aid Thermo Fisher in advancing precision medicine and enhancing the understanding of human biology. Olink's proteomics solutions are complementary to Thermo Fisher's life sciences and mass spectrometry offerings and are expected to allow the latter to accelerate scientific breakthroughs and drug discovery.
The leading market players are also investing in expanding their production facilities to boost the production of different products and technologies. In June 2024, Bruker Corporation opened its production facility in Bremen, Germany. This event is a significant milestone in the company's commitment to ensure collaboration, innovation, and sustainability in the field of mass spectrometry. The facility is also expected to aid the company in meeting the growing demands for its products that are actively being adopted in various fields, including clinical proteomics, environmental analysis, and microbiology.
Table of Contents
1. Project Scope and Definitions
2. Research Methodology
3. Executive Summary
4. Global Proteomics Market Outlook, 2018-2032F
- 4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
- 4.2. Market Share Analysis & Forecast
- 4.2.1. By Products and Services
- 4.2.1.1. Instruments
- 4.2.1.2. Reagents and Consumables
- 4.2.1.3. Services
- 4.2.2. By Technology
- 4.2.2.1. Spectrometry
- 4.2.2.2. Electrophoresis
- 4.2.2.3. Chromatography
- 4.2.2.4. Microarray Instruments
- 4.2.2.5. X-Ray Crystallography
- 4.2.2.6. Next-generation Sequencing
- 4.2.2.7. Protein Fractionation Systems
- 4.2.2.8. Surface Plasma Resonance (SPR) Systems
- 4.2.2.9. Others
- 4.2.3. By Application
- 4.2.3.1. Drug Discovery and Development
- 4.2.3.2. Disease Diagnosis
- 4.2.3.3. Others
- 4.2.4. By End-user
- 4.2.4.1. Academic and Research Institutes
- 4.2.4.2. Clinical Laboratories and Hospitals
- 4.2.4.3. Pharmaceutical and Biotechnology Companies
- 4.2.4.4. Others
- 4.2.5. By Region
- 4.2.5.1. North America
- 4.2.5.2. Europe
- 4.2.5.3. Asia-Pacific
- 4.2.5.4. South America
- 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
- 4.2.1. By Products and Services
- 4.3. Market Map Analysis, 2024
- 4.3.1. By Products and Services
- 4.3.2. By Technology
- 4.3.3. By Application
- 4.3.4. By End-user
- 4.3.5. By Region
5. North America Proteomics Market Outlook, 2018-2032F*
- 5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.2. Market Share Analysis & Forecast
- 5.2.1. By Products and Services
- 5.2.1.1. Instruments
- 5.2.1.2. Reagents and Consumables
- 5.2.1.3. Services
- 5.2.2. By Technology
- 5.2.2.1. Spectrometry
- 5.2.2.2. Electrophoresis
- 5.2.2.3. Chromatography
- 5.2.2.4. Microarray Instruments
- 5.2.2.5. X-Ray Crystallography
- 5.2.2.6. Next-generation Sequencing
- 5.2.2.7. Protein Fractionation Systems
- 5.2.2.8. Surface Plasma Resonance (SPR) Systems
- 5.2.2.9. Others
- 5.2.3. By Application
- 5.2.3.1. Drug Discovery and Development
- 5.2.3.2. Disease Diagnosis
- 5.2.3.3. Others
- 5.2.4. By End-user
- 5.2.4.1. Academic and Research Institutes
- 5.2.4.2. Clinical Laboratories and Hospitals
- 5.2.4.3. Pharmaceutical and Biotechnology Companies
- 5.2.4.4. Others
- 5.2.5. By Country Share
- 5.2.5.1. United States
- 5.2.5.2. Canada
- 5.2.5.3. Mexico
- 5.2.1. By Products and Services
- 5.3. Country Market Assessment
- 5.3.1. United States Proteomics Market Outlook, 2018-2032F*
- 5.3.1.1. Market Size Analysis & Forecast
- 5.3.1.1.1. By Value
- 5.3.1.2. Market Share Analysis & Forecast
- 5.3.1.2.1. By Products and Services
- 5.3.1.2.1.1. Instruments
- 5.3.1.2.1.2. Reagents and Consumables
- 5.3.1.2.1.3. Services
- 5.3.1.2.2. By Technology
- 5.3.1.2.2.1. Spectrometry
- 5.3.1.2.2.2. Electrophoresis
- 5.3.1.2.2.3. Chromatography
- 5.3.1.2.2.4. Microarray Instruments
- 5.3.1.2.2.5. X-Ray Crystallography
- 5.3.1.2.2.6. Next-generation Sequencing
- 5.3.1.2.2.7. Protein Fractionation Systems
- 5.3.1.2.2.8. Surface Plasma Resonance (SPR) Systems
- 5.3.1.2.2.9. Others
- 5.3.1.2.3. By Application
- 5.3.1.2.3.1. Drug Discovery and Development
- 5.3.1.2.3.2. Disease Diagnosis
- 5.3.1.2.3.3. Others
- 5.3.1.2.4. By End-user
- 5.3.1.2.4.1. Academic and Research Institutes
- 5.3.1.2.4.2. Clinical Laboratories and Hospitals
- 5.3.1.2.4.3. Pharmaceutical and Biotechnology Companies
- 5.3.1.2.4.4. Others
- 5.3.1.2.1. By Products and Services
- 5.3.1.1. Market Size Analysis & Forecast
- 5.3.2. Canada
- 5.3.3. Mexico
- 5.3.1. United States Proteomics Market Outlook, 2018-2032F*
All segments will be provided for all regions and countries covered
6. Europe Proteomics Market Outlook, 2018-2032F
- 6.1. Germany
- 6.2. France
- 6.3. Italy
- 6.4. United Kingdom
- 6.5. Russia
- 6.6. Netherlands
- 6.7. Spain
- 6.8. Poland
7. Asia-Pacific Proteomics Market Outlook, 2018-2032F
- 7.1. India
- 7.2. China
- 7.3. Japan
- 7.4. Australia
- 7.5. Vietnam
- 7.6. South Korea
- 7.7. Indonesia
- 7.8. Philippines
8. South America Proteomics Market Outlook, 2018-2032F
- 8.1. Brazil
- 8.2. Argentina
9. Middle East and Africa Proteomics Market Outlook, 2018-2032F
- 9.1. Saudi Arabia
- 9.2. UAE
- 9.3. South Africa
- 9.4. Israel
10. Demand Supply Analysis
11. Value Chain Analysis
12. Porter's Five Forces Analysis
13. PESTLE Analysis
14. Pricing Analysis
15. Market Dynamics
- 15.1. Market Drivers
- 15.2. Market Challenges
16. Market Trends and Developments
17. Regulatory Framework and Innovation
- 17.1. Regulatory Approvals
18. Patent Landscape
19. Case Studies
20. Competitive Landscape
- 20.1. Competition Matrix of Top 5 Market Leaders
- 20.2. SWOT Analysis for Top 5 Players
- 20.3. Key Players Landscape for Top 10 Market Players
- 20.3.1. Thermo Fisher Scientific Inc.
- 20.3.1.1. Company Details
- 20.3.1.2. Key Management Personnel
- 20.3.1.3. Products and Services
- 20.3.1.4. Financials (As Reported)
- 20.3.1.5. Key Market Focus and Geographical Presence
- 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 20.3.2. Danaher Corporation
- 20.3.3. Agilent Technologies, Inc.
- 20.3.4. Illumina, Inc.
- 20.3.5. Bio-Rad Laboratories, Inc.
- 20.3.6. Merck KGaA
- 20.3.7. Waters Corporation
- 20.3.8. Bruker Corporation
- 20.3.9. PerkinElmer AES
- 20.3.10. Shimadzu Corporation
- 20.3.1. Thermo Fisher Scientific Inc.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
21. Strategic Recommendations
22. About Us and Disclaimer
List of Tables
- Table 1. Competition Matrix of Top 5 Market Leaders
- Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
- Table 3. About Us - Regions and Countries Where We Have Executed Client Projects
List of Figures
- Figure 1. Global Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 2. Global Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 3. Global Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 4. Global Proteomics Market Share (%), By Application, 2018-2032F
- Figure 5. Global Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 6. Global Proteomics Market Share (%), By Region, 2018-2032F
- Figure 7. North America Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 8. North America Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 9. North America Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 10. North America Proteomics Market Share (%), By Application, 2018-2032F
- Figure 11. North America Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 12. North America Proteomics Market Share (%), By Country, 2018-2032F
- Figure 13. United States Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 14. United States Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 15. United States Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 16. United States Proteomics Market Share (%), By Application, 2018-2032F
- Figure 17. United States Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 18. Canada Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 19. Canada Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 20. Canada Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 21. Canada Proteomics Market Share (%), By Application, 2018-2032F
- Figure 22. Canada Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 23. Mexico Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 24. Mexico Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 25. Mexico Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 26. Mexico Proteomics Market Share (%), By Application, 2018-2032F
- Figure 27. Mexico Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 28. Europe Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 29. Europe Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 30. Europe Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 31. Europe Proteomics Market Share (%), By Application, 2018-2032F
- Figure 32. Europe Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 33. Europe Proteomics Market Share (%), By Country, 2018-2032F
- Figure 34. Germany Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 35. Germany Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 36. Germany Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 37. Germany Proteomics Market Share (%), By Application, 2018-2032F
- Figure 38. Germany Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 39. France Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 40. France Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 41. France Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 42. France Proteomics Market Share (%), By Application, 2018-2032F
- Figure 43. France Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 44. Italy Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 45. Italy Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 46. Italy Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 47. Italy Proteomics Market Share (%), By Application, 2018-2032F
- Figure 48. Italy Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 49. United Kingdom Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 50. United Kingdom Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 51. United Kingdom Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 52. United Kingdom Proteomics Market Share (%), By Application, 2018-2032F
- Figure 53. United Kingdom Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 54. Russia Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 55. Russia Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 56. Russia Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 57. Russia Proteomics Market Share (%), By Application, 2018-2032F
- Figure 58. Russia Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 59. Netherlands Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 60. Netherlands Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 61. Netherlands Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 62. Netherlands Proteomics Market Share (%), By Application, 2018-2032F
- Figure 63. Netherlands Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 64. Spain Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 65. Spain Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 66. Spain Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 67. Spain Proteomics Market Share (%), By Application, 2018-2032F
- Figure 68. Spain Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 69. Turkey Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 70. Turkey Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 71. Turkey Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 72. Turkey Proteomics Market Share (%), By Application, 2018-2032F
- Figure 73. Turkey Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 74. Poland Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 75. Poland Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 76. Poland Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 77. Poland Proteomics Market Share (%), By Application, 2018-2032F
- Figure 78. Poland Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 79. South America Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 80. South America Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 81. South America Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 82. South America Proteomics Market Share (%), By Application, 2018-2032F
- Figure 83. South America Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 84. South America Proteomics Market Share (%), By Country, 2018-2032F
- Figure 85. Brazil Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 86. Brazil Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 87. Brazil Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 88. Brazil Proteomics Market Share (%), By Application, 2018-2032F
- Figure 89. Brazil Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 90. Argentina Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 91. Argentina Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 92. Argentina Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 93. Argentina Proteomics Market Share (%), By Application, 2018-2032F
- Figure 94. Argentina Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 95. Asia-Pacific Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 96. Asia-Pacific Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 97. Asia-Pacific Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 98. Asia-Pacific Proteomics Market Share (%), By Application, 2018-2032F
- Figure 99. Asia-Pacific Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 100. Asia-Pacific Proteomics Market Share (%), By Country, 2018-2032F
- Figure 101. India Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 102. India Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 103. India Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 104. India Proteomics Market Share (%), By Application, 2018-2032F
- Figure 105. India Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 106. China Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 107. China Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 108. China Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 109. China Proteomics Market Share (%), By Application, 2018-2032F
- Figure 110. China Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 111. Japan Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 112. Japan Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 113. Japan Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 114. Japan Proteomics Market Share (%), By Application, 2018-2032F
- Figure 115. Japan Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 116. Australia Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 117. Australia Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 118. Australia Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 119. Australia Proteomics Market Share (%), By Application, 2018-2032F
- Figure 120. Australia Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 121. Vietnam Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 122. Vietnam Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 123. Vietnam Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 124. Vietnam Proteomics Market Share (%), By Application, 2018-2032F
- Figure 125. Vietnam Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 126. South Korea Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 127. South Korea Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 128. South Korea Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 129. South Korea Proteomics Market Share (%), By Application, 2018-2032F
- Figure 130. South Korea Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 131. Indonesia Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 132. Indonesia Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 133. Indonesia Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 134. Indonesia Proteomics Market Share (%), By Application, 2018-2032F
- Figure 135. Indonesia Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 136. Philippines Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 137. Philippines Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 138. Philippines Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 139. Philippines Proteomics Market Share (%), By Application, 2018-2032F
- Figure 140. Philippines Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 141. Middle East & Africa Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 142. Middle East & Africa Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 143. Middle East & Africa Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 144. Middle East & Africa Proteomics Market Share (%), By Application, 2018-2032F
- Figure 145. Middle East & Africa Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 146. Middle East & Africa Proteomics Market Share (%), By Country, 2018-2032F
- Figure 147. Saudi Arabia Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 148. Saudi Arabia Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 149. Saudi Arabia Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 150. Saudi Arabia Proteomics Market Share (%), By Application, 2018-2032F
- Figure 151. Saudi Arabia Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 152. UAE Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 153. UAE Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 154. UAE Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 155. UAE Proteomics Market Share (%), By Application, 2018-2032F
- Figure 156. UAE Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 157. South Africa Proteomics Market, By Value, In USD Billion, 2018-2032F
- Figure 158. South Africa Proteomics Market Share (%), By Products and Services, 2018-2032F
- Figure 159. South Africa Proteomics Market Share (%), By Technology, 2018-2032F
- Figure 160. South Africa Proteomics Market Share (%), By Application, 2018-2032F
- Figure 161. South Africa Proteomics Market Share (%), By End-user, 2018-2032F
- Figure 162. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 163. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
